FORMULA-509 probes salvage radiation and gonadotropin-releasing hormone routine

On this video, Paul Nguyen, MD, a genitourinary radiation oncologist at Dana-Farber Most cancers Institute, discusses the FORMULA-509 trial he co-presented at ASCO Genitourinary Cancers Symposium.

The research examined sufferers with a rising PSA after radical prostatectomy who had no less than one unfavorable danger issue, and who acquired salvage radiation and 6 months of a gonadotropin-releasing hormone agonist.

“What I feel we will say now could be for a affected person as we speak, utilizing the FORMULA-509 routine is a really engaging various to having to elongate the length of hormone remedy to 24 months,” Nguyen mentioned.

Reference:

• Nguyen P, et al. FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or with out abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP). Introduced at: ASCO Genitourinary Cancers Symposium; ; Feb. 16-18, 2023; San Francisco.

ADD TOPIC TO EMAIL ALERTS

Obtain an electronic mail when new articles are posted on

Please present your electronic mail tackle to obtain an electronic mail when new articles are posted on .

” data-action=subscribe>
Subscribe

We have been unable to course of your request. Please attempt once more later. In case you proceed to have this situation please contact customerservice@slackinc.com.

Again to Healio

Take Houses in Prostate Most cancers